NervGen Pharma Statistics
NASDAQ: NGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.75+0.01 (+0.57%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NervGen Pharma by the numbers
NervGen Pharma has a market capitalization of $188.2 million based on 107.52M shares outstanding. With trailing EPS of $-0.57, NervGen Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.0% below its 50-day average and 44.6% below its 200-day average.
Average daily trading volume is 565.19K shares, or about $989,083 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NGEN valuation vs. peer median
| Metric | NGEN | Peer median | Difference |
|---|---|---|---|
| Market cap | $188.16M | $175.66M | +7% |
| Avg. volume | 565.19K | 509.85K | +11% |
Peer median across 8 companies: YARW, ANTX, ORMP, ELDN, DERM, ADCT, ORGO, PEPG.
Valuation
- Market cap
- $188.16M
- EPS (TTM)
- $-0.57
- Shares outstanding
- 107.52M
Price and trading
- Previous close
- 1.74
- Open
- 1.74
- Day range
- 1.72 – 1.81
- 52-week range
- 1.58 – 6.30
- 52-week change
- -48.18%
- Beta
- —
- Volume
- 288.93K
- Average volume
- 565.19K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 188.16M
- Forward Pe
- -5.13
- Eps
- -0.57
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.30
- Week52 Low
- 1.58
- Avg Volume
- 565.19K
- Shares Outstanding
- 107.52M
- Ma50
- 1.94
- Ma200
- 3.16
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -72.22%
- Pct From52w Low
- 10.76%